NewAmsterdam Pharma Co. NV (NAMS)
20.50
+0.97
(+4.97%)
USD |
NASDAQ |
Oct 27, 16:00
20.50
0.00 (0.00%)
After-Hours: 20:00
NewAmsterdam Pharma Price to Book Value : 3.820 for Oct. 27, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 3.820 |
| October 26, 2026 | 3.639 |
| October 23, 2026 | 3.672 |
| October 22, 2026 | 4.021 |
| October 21, 2026 | 4.004 |
| October 20, 2026 | 4.006 |
| October 19, 2026 | 3.814 |
| October 16, 2026 | 3.695 |
| October 15, 2026 | 3.842 |
| October 14, 2026 | 3.728 |
| October 13, 2026 | 3.762 |
| October 12, 2026 | 3.960 |
| October 09, 2026 | 4.02 |
| October 08, 2026 | 3.961 |
| October 07, 2026 | 4.123 |
| October 06, 2026 | 4.150 |
| October 05, 2026 | 4.248 |
| October 02, 2026 | 4.323 |
| October 01, 2026 | 4.502 |
| September 30, 2026 | 4.532 |
| September 29, 2026 | 4.436 |
| September 28, 2026 | 4.394 |
| September 25, 2026 | 4.207 |
| September 24, 2026 | 4.237 |
| September 23, 2026 | 4.226 |
| Date | Value |
|---|---|
| September 22, 2026 | 4.345 |
| September 21, 2026 | 4.207 |
| September 18, 2026 | 4.190 |
| September 17, 2026 | 4.086 |
| September 16, 2026 | 3.946 |
| September 15, 2026 | 3.943 |
| September 14, 2026 | 4.166 |
| September 11, 2026 | 4.248 |
| September 10, 2026 | 4.073 |
| September 09, 2026 | 4.246 |
| September 08, 2026 | 4.776 |
| September 04, 2026 | 4.733 |
| September 03, 2026 | 4.817 |
| September 02, 2026 | 4.768 |
| September 01, 2026 | 4.643 |
| August 31, 2026 | 4.722 |
| August 28, 2026 | 4.826 |
| August 27, 2026 | 4.992 |
| August 26, 2026 | 5.105 |
| August 25, 2026 | 5.094 |
| August 24, 2026 | 5.003 |
| August 21, 2026 | 5.193 |
| August 20, 2026 | 5.176 |
| August 19, 2026 | 5.316 |
| August 18, 2026 | 5.077 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ProQR Therapeutics NV | 2.081 |
| Pharming Group NV | 3.269 |
| argenx SE | -- |
| Alnylam Pharmaceuticals, Inc. | 22.40 |
| Ionis Pharmaceuticals, Inc. | 16.56 |
Price to Book Value Related Metrics
| PS Ratio | 344.37 |
| PEG Ratio | -0.2685 |
| Price | 20.50 |
| Earnings Yield | -10.62% |
| Market Cap | 2.412B |
| PEGY Ratio | -0.2685 |